R-AXSPA

Clinical trials for R-AXSPA explained in plain language.

Never miss a new study

Get alerted when new R-AXSPA trials appear

Sign up with your email to follow new studies for R-AXSPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug shows promise for Long-Term control of spinal arthritis

Disease control Ongoing

This study looks at the long-term safety and effectiveness of a drug called bimekizumab for people with active axial spondyloarthritis, a type of arthritis that mainly affects the spine. About 500 adults who completed a previous bimekizumab study will continue taking the drug for…

Matched conditions: R-AXSPA

Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated May 09, 2026 09:38 UTC

R-AXSPA

Get alerted when new R-AXSPA trials appear

New drug shows promise for Long-Term control of spinal arthritis